[Tuberculosis in HIV positive individuals].
Tuberculosis (TB) is worldwide one of the leading causes of death in HIV infected individuals. In Chile, TB rates have fallen dramatically in the general population and new cases are being progressively restricted to high risk groups, particularly immunosuppressed individuals. In these patients diagnostic tests have decreased sensitivity and TB frequently evolves to disseminated and rapidly progressive forms. Besides, the concurrent treatment of HIV infection and TB adds further toxicities and the possibility of significant interactions. In this article we review the particularities and advances in diagnostic and therapeutic aspects of TB in the HIV infected patient.
Balcells M
M Elvira
ME
Pontificia Universidad Católica de Chile, Santiago. balcells@med.puc.cl
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D006801:Humans; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control
D019380:Anti-HIV Agents; D000995:Antitubercular Agents